Houlihan Lokey Advises MatrixCare
Transaction Pending
MatrixCare, a subsidiary of
Resmed, has agreed to be
acquired by Frazier
Healthcare Partners
Sellside Advisor
Houlihan Lokey is pleased to announce that MatrixCare, a subsidiary of Resmed, has agreed to be acquired by Frazier Healthcare Partners (Frazier).
The sale reflects Resmed’s 2030 strategy by focusing on high-growth, scalable opportunities in sleep health, breathing health, and connected home-based healthcare. The divestiture also strengthens Resmed’s ability to reallocate capital and resources toward innovation, operational scale, and long-term value creation across its connected, home-based care ecosystem.
MatrixCare provides software solutions to more than 15,000 providers supporting skilled nursing, senior living and long-term care, life planning communities, and home health and hospice care. A multi-year winner of the Best in KLAS award, MatrixCare is trusted by thousands of facility-based and home-based care organizations to improve provider efficiencies and promote a better quality of life for the people they serve.
Resmed (NYSE:RMD, ASX:RMD) creates life-changing health technologies that people love. Resmed is relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Their AI-powered digital health solutions, cloud-connected devices, and intelligent software make home healthcare more personalized, accessible, and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home.
Founded in 1991, Frazier Healthcare Partners is a private equity firm focused exclusively on the healthcare industry. Since its inception, Frazier has raised over $11 billion of capital for private funds and co-investment opportunities and has invested in more than 200 companies over 35 years. Frazier has a philosophy of partnering with strong management teams while leveraging its internal operating resources and network to build exceptional companies. Frazier is headquartered in Seattle, with an office in New York City, and invests broadly across the U.S., Canada, and Europe.
Houlihan Lokey served as the exclusive sellside advisor to Resmed. This transaction illustrates the Healthcare Technology team’s continued leadership and represents the 20th transaction the firm has advised on in the past 24 months, comprising ~$10B billion in aggregate enterprise value.